The 2.6 angstrom structure of antithrombin indicates a conformational change at the heparin binding site

被引:177
作者
Skinner, R [1 ]
Abrahams, JP [1 ]
Whisstock, JC [1 ]
Lesk, AM [1 ]
Carrell, RW [1 ]
Wardell, MR [1 ]
机构
[1] UNIV CAMBRIDGE, CTR MRC, MRC, MOL BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND
基金
英国惠康基金;
关键词
antithrombin; 2.6 angstrom structure; X-ray crystallography; heparin-pentasaccharide binding; dimer;
D O I
10.1006/jmbi.1996.0798
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of a dimeric form of intact antithrombin has been solved to 2.6 Angstrom, representing the highest-resolution structure of an active, inhibitory serpin to date. The crystals were grown under microgravity conditions on Space Shuttle mission STS-67. The overall confidence in the structure, determined earlier from lower resolution data, is increased and new insights into the structure-function relationship are gained. Clear and continuous electron density is present for the reactive centre loop region P12 to P14 inserting into the top of the A-beta-sheet. Areas of the extended amino terminus, unique to antithrombin and important in the binding of the glycosaminoglycan heparin, can now be traced further than in the earlier structures. As in the earlier studies, the crystals contain one active and one latent molecule per asymmetric unit. Better definition of the electron density surrounding the D-helix and of the residues implicated in the binding of the heparin pentasaccharide (Arg47, Lys114, Lys125, Arg129) provides an insight into the change of affinity of binding that accompanies the change in conformation. In particular, the observed hydrogen bonding of these residues to the body of the molecule in the latent form explains the mechanism for the release of newly formed antithrombin-protease complexes into the circulation for catabolic removal. (C) 1997 Academic Press Limited.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 43 条
[11]   STRUCTURE-ACTIVITY RELATIONSHIP IN HEPARIN - A SYNTHETIC PENTASACCHARIDE WITH HIGH-AFFINITY FOR ANTI-THROMBIN-III AND ELICITING HIGH ANTI-FACTOR-XA ACTIVITY [J].
CHOAY, J ;
PETITOU, M ;
LORMEAU, JC ;
SINAY, P ;
CASU, B ;
GATTI, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (02) :492-499
[12]   PROPERTIES OF ANTI-THROMBIN THROMBIN COMPLEX FORMED IN THE PRESENCE AND IN THE ABSENCE OF HEPARIN [J].
DANIELSSON, A ;
BJORK, I .
BIOCHEMICAL JOURNAL, 1983, 213 (02) :345-353
[13]   BINDING OF HEPARIN TO HUMAN ANTITHROMBIN III AS STUDIED BY MEASUREMENTS OF TRYPTOPHAN FLUORESCENCE [J].
EINARSSON, R ;
ANDERSSON, LO .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 490 (01) :104-111
[14]   LYSINE-HEPARIN INTERACTIONS IN ANTITHROMBIN - PROPERTIES OF K125M AND K290M,K294M,K297M VARIANTS [J].
FAN, BQ ;
TURKO, IV ;
GETTINS, PGW .
BIOCHEMISTRY, 1994, 33 (47) :14156-14161
[15]  
GANDRILLE S, 1990, J BIOL CHEM, V265, P18997
[16]   ANTITHROMBIN-III AND ITS INTERACTION WITH HEPARIN - COMPARISON OF THE HUMAN, BOVINE, AND PORCINE PROTEINS BY H-1-NMR SPECTROSCOPY [J].
GETTINS, P .
BIOCHEMISTRY, 1987, 26 (05) :1391-1398
[17]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[18]   ANTITHROMBIN-III TOYAMA - REPLACEMENT OF ARGININE-47 BY CYSTEINE IN HEREDITARY ABNORMAL ANTITHROMBIN-III THAT LACKS HEPARIN-BINDING ABILITY [J].
KOIDE, T ;
ODANI, S ;
TAKAHASHI, K ;
ONO, T ;
SAKURAGAWA, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (02) :289-293
[19]   MOLSCRIPT - A PROGRAM TO PRODUCE BOTH DETAILED AND SCHEMATIC PLOTS OF PROTEIN STRUCTURES [J].
KRAULIS, PJ .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :946-950
[20]   Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III [J].
Kridel, SJ ;
Chan, WW ;
Knauer, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20935-20941